{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T07:01:09Z","timestamp":1790060469907,"version":"4.0.1"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"vor","delay-in-days":21,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background &amp; Aims<\/jats:title>\n                    <jats:p>Orofacial granulomatosis (OFG) is strongly associated with Crohn\u2019s disease (CD). The CD phenotype associated with OFG is poorly defined, and there is little evidence regarding treatment. We aimed to characterize OFG-associated CD phenotypes and evaluate the response of OFG to advanced therapies in the largest cohort described to date.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective cohort study of patients with OFG and CD from two UK centers, derived from patient records compiled since 2008. Phenotypic characteristics were compared with a CD control cohort of 1609 individuals without OFG from the NIHR IBD-BioResource. Clinical response to biologic\/Janus kinase inhibitor (JAKi) therapies was assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 117 patients were included. Compared with controls, OFG was associated with earlier CD diagnosis (&amp;lt;17\u2009years: 43% vs 22%, P\u2009&amp;lt;\u2009.001), increased ileocolonic disease (61% vs 41%, P\u2009&amp;lt;\u2009.001), perianal disease (46% vs 35%, P\u2009=\u2009.012), and upper gastrointestinal disease (21% vs 8%, P\u2009&amp;lt;\u2009.001). Clinical remission was achieved in 29 of 53 (55%) prescribed infliximab and 35 of 59 (59%) prescribed adalimumab, with frequent dose escalation. Remission was achieved with ustekinumab, risankizumab, and upadacitinib in 14 of 25 (56%), 6 of 12 (50%), and 3 of 5 (60%), respectively in biologic-experienced patients. Higher anti-TNF drug levels were associated with higher odds of achieving treatment response (adalimumab OR 1.14 per 1\u2009\u00b5g\/mL increase, P\u2009=\u2009.049; infliximab OR 1.27, P\u2009=\u2009.047).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>OFG is associated with a distinct CD phenotype characterized by frequent UGI and perianal involvement. Advanced therapies, including anti-TNF, anti-IL23, and JAKi therapies, are effective, with evidence supporting dose optimization.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ecco-jcc\/jjag139","type":"journal-article","created":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T11:39:27Z","timestamp":1788867567000},"source":"Crossref","is-referenced-by-count":0,"title":["Orofacial granulomatosis associated with Crohn\u2019s disease: clinical phenotype and response to biologics and Janus kinase inhibitor therapy in a large multi-center cohort"],"prefix":"10.1093","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-7439-1681","authenticated-orcid":false,"given":"Robert D","family":"Lees","sequence":"first","affiliation":[{"name":"Translational and Clinical Research Institute, Newcastle University , Newcastle upon Tyne,","place":["United Kingdom"]},{"name":"The Newcastle upon Tyne Hospitals NHS Foundation Trust Department of Gastroenterology, , Newcastle upon Tyne,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Patel","sequence":"additional","affiliation":[{"name":"Guy\u2019s and St Thomas\u2019 NHS Foundation Trust Department of Gastroenterology, , London,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5342-1421","authenticated-orcid":false,"given":"Gregory","family":"Young","sequence":"additional","affiliation":[{"name":"Translational and Clinical Research Institute, Newcastle University , Newcastle upon Tyne,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8470-9679","authenticated-orcid":false,"given":"Lauren","family":"Beck","sequence":"additional","affiliation":[{"name":"Translational and Clinical Research Institute, Newcastle University , Newcastle upon Tyne,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelica Molinillo","family":"Marin","sequence":"additional","affiliation":[{"name":"Guy\u2019s and St Thomas\u2019 NHS Foundation Trust Department of Gastroenterology, , London,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Parkinson","sequence":"additional","affiliation":[{"name":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom Department of Cellular Pathology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laetitia","family":"Pele","sequence":"additional","affiliation":[{"name":"NIHR BioResource for Translational Research , Cambridge,","place":["United Kingdom"]},{"name":"Department of Haematology, University of Cambridge , Cambridge,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6467-0631","authenticated-orcid":false,"given":"Miles","family":"Parkes","sequence":"additional","affiliation":[{"name":"NIHR BioResource for Translational Research , Cambridge,","place":["United Kingdom"]},{"name":"Cambridge University Hospitals NHS Foundation Trust Department of Gastroenterology, , Cambridge,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Sanderson","sequence":"additional","affiliation":[{"name":"Guy\u2019s and St Thomas\u2019 NHS Foundation Trust Department of Gastroenterology, , London,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5832-2135","authenticated-orcid":false,"given":"Cameron","family":"Herbert","sequence":"additional","affiliation":[{"name":"Guy's and St Thomas\u2019 NHS Foundation Trust, London, United Kingdom Department of Oral Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2895-1591","authenticated-orcid":false,"given":"Esther","family":"Hullah","sequence":"additional","affiliation":[{"name":"Guy's and St Thomas\u2019 NHS Foundation Trust, London, United Kingdom Department of Oral Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7271-4956","authenticated-orcid":false,"given":"Christopher A","family":"Lamb","sequence":"additional","affiliation":[{"name":"Translational and Clinical Research Institute, Newcastle University , Newcastle upon Tyne,","place":["United Kingdom"]},{"name":"The Newcastle upon Tyne Hospitals NHS Foundation Trust Department of Gastroenterology, , Newcastle upon Tyne,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Mawdsley","sequence":"additional","affiliation":[{"name":"Guy\u2019s and St Thomas\u2019 NHS Foundation Trust Department of Gastroenterology, , London,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3184-9181","authenticated-orcid":false,"given":"Richard Ally","family":"Speight","sequence":"additional","affiliation":[{"name":"Translational and Clinical Research Institute, Newcastle University , Newcastle upon Tyne,","place":["United Kingdom"]},{"name":"The Newcastle upon Tyne Hospitals NHS Foundation Trust Department of Gastroenterology, , Newcastle upon Tyne,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,21]]},"reference":[{"key":"2026092202070290700_jjag139-B1","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/00054725-200606000-00011","article-title":"Improvement in orofacial granulomatosis on a cinnamon- and benzoate-free diet","volume":"12","author":"White","year":"2006","journal-title":"Inflamm Bowel Dis"},{"key":"2026092202070290700_jjag139-B2","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1440-0960.2004.00071.x","article-title":"Possible role of Mycobacterium tuberculosis complex in Melkersson-Rosenthal syndrome demonstrated with Gen-Probe amplified Mycobacterium tuberculosis direct test","volume":"45","author":"Apaydin","year":"2004","journal-title":"Australas J Dermatol"},{"key":"2026092202070290700_jjag139-B3","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/qjmed\/93.8.507","article-title":"The role of allergy in oral mucosal diseases","volume":"93","author":"Wray","year":"2000","journal-title":"QJM"},{"key":"2026092202070290700_jjag139-B4","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1097\/01.MIB.0000178261.88356.67","article-title":"Oro-facial granulomatosis: Crohn\u2019s disease or a new inflammatory bowel disease?","volume":"11","author":"Sanderson","year":"2005","journal-title":"Inflamm Bowel Dis"},{"key":"2026092202070290700_jjag139-B5","doi-asserted-by":"crossref","first-page":"7497","DOI":"10.3748\/wjg.v20.i23.7497","article-title":"Association between orofacial granulomatosis and Crohn\u2019s disease in children: systematic review","volume":"20","author":"Lazzerini","year":"2014","journal-title":"World J Gastroenterol"},{"key":"2026092202070290700_jjag139-B6","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1097\/MIB.0000000000000670","article-title":"Does Crohn\u2019s disease with concomitant orofacial granulomatosis represent a distinctive disease subtype?","volume":"22","author":"Gale","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"2026092202070290700_jjag139-B7","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1159\/000513446","article-title":"Orofacial granulomatosis and Crohn disease: coincidence or pattern? A systematic review","volume":"237","author":"Gavioli","year":"2021","journal-title":"Dermatology"},{"key":"2026092202070290700_jjag139-B8","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1002\/ibd.21599","article-title":"Distinguishing orofacial granulomatosis from Crohn\u2019s disease: two separate disease entities?","volume":"17","author":"Campbell","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"2026092202070290700_jjag139-B9","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1093\/ecco-jcc\/jjab158","article-title":"Orofacial granulomatosis associated with Crohn\u2019s disease: a multicentre case series","volume":"16","author":"Phillips","year":"2022","journal-title":"J Crohns Colitis"},{"key":"2026092202070290700_jjag139-B10","doi-asserted-by":"crossref","first-page":"e01559","DOI":"10.14309\/crj.0000000000001559","article-title":"Orofacial granulomatosis and Crohn\u2019s disease: a case series","volume":"11","author":"Urquhart","year":"2024","journal-title":"ACG Case Rep J"},{"key":"2026092202070290700_jjag139-B11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12968\/hmed.2022.0416","article-title":"Management of orofacial granulomatosis","volume":"29","author":"Joshi","year":"2023","journal-title":"Br J Hosp Med (Lond)"},{"key":"2026092202070290700_jjag139-B12","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1600-0714.2010.00976.x","article-title":"Experience with anti-TNF-alpha therapy for orofacial granulomatosis","volume":"40","author":"Elliott","year":"2011","journal-title":"J Oral Pathol Med"},{"key":"2026092202070290700_jjag139-B13","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S2468-1253(24)00034-7","article-title":"A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn\u2019s disease (PROFILE): a multicentre, open-label randomised controlled trial","volume":"9","author":"Noor","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2026092202070290700_jjag139-B14","article-title":"Efficacy and safety of upadacitinib and vedolizumab combination for refractory orofacial granulomatosis associated with panenteric Crohn\u2019s disease: a case report","volume":"8","author":"Campigotto","year":"2025","journal-title":"Reports (MDPI)"},{"key":"2026092202070290700_jjag139-B15","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1093\/ibd\/izaa123","article-title":"Using ustekinumab to treat Crohn\u2019s disease-related orofacial granulomatosis: two birds, one stone","volume":"26","author":"Gilmore","year":"2020","journal-title":"Inflamm Bowel Dis"},{"key":"2026092202070290700_jjag139-B16","doi-asserted-by":"crossref","first-page":"e442","DOI":"10.1111\/jdv.20486","article-title":"Upadacitinib for orofacial granulomatosis associated with Crohn\u2019s disease","volume":"39","author":"Colin","year":"2025","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2026092202070290700_jjag139-B17","first-page":"A70","article-title":"P47 Response of orofacial granulomatosis to biologics in patients with inflammatory bowel disease","volume":"72","author":"Moore","year":"2023","journal-title":"Gut"},{"key":"2026092202070290700_jjag139-B18","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1007\/s10620-023-07821-8","article-title":"Frequent occurrence of perianal disease and granuloma formation in patients with Crohn\u2019s disease and coexistent orofacial granulomatosis","volume":"68","author":"Malmquist","year":"2023","journal-title":"Dig Dis Sci"},{"key":"2026092202070290700_jjag139-B19","doi-asserted-by":"crossref","first-page":"6020","DOI":"10.1038\/s41598-025-90243-5","article-title":"Fecal microbiota and genetics in pediatric-onset orofacial granulomatosis and Crohn s disease","volume":"15","author":"H\u00f6yhty\u00e4","year":"2025","journal-title":"Sci Rep"},{"key":"2026092202070290700_jjag139-B20","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1136\/gutjnl-2019-318835","article-title":"IBD BioResource: an open-access platform of 25 000 patients to accelerate research in Crohn\u2019s and Colitis","volume":"68","author":"Parkes","year":"2019","journal-title":"Gut"},{"key":"2026092202070290700_jjag139-B21","doi-asserted-by":"crossref","first-page":"5A","DOI":"10.1155\/2005\/269076","article-title":"Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology","volume":"19","author":"Silverberg","year":"2005","journal-title":"Can J Gastroenterol."},{"key":"2026092202070290700_jjag139-B22","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/s41395-018-0073-0","article-title":"Prospective observational evaluation of time-dependency of adalimumab immunogenicity and drug concentrations: the POETIC Study","volume":"113","author":"Ungar","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"2026092202070290700_jjag139-B23","first-page":"97","article-title":"Human mucosal addressin cell adhesion molecule-1 is preferentially expressed in intestinal tract and associated lymphoid tissue","volume":"151","author":"Briskin","year":"1997","journal-title":"Am J Pathol"}],"container-title":["Journal of Crohn's and Colitis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/20\/9\/jjag139\/71300177\/jjag139.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/20\/9\/jjag139\/71300177\/jjag139.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T06:07:12Z","timestamp":1790057232000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article\/doi\/10.1093\/ecco-jcc\/jjag139\/8826379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":23,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9,3]]}},"URL":"https:\/\/doi.org\/10.1093\/ecco-jcc\/jjag139","relation":{},"ISSN":["1873-9946","1876-4479"],"issn-type":[{"value":"1873-9946","type":"print"},{"value":"1876-4479","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,9]]},"article-number":"jjag139"}}